SMA (smooth muscle antibody) (97.2%) and Desmin (94.5%) are positive in most smooth muscle tumor patients, serving as markers of smooth muscle cells and being helpful in confirming myogenic tumors (11). The gene discussed is DES; the disease is smooth muscle tumor.